April 17, 2019 / 6:28 AM / 2 months ago

BRIEF-AB Science Presents New Preclinical Data For Masitinib In ALS

April 17(Reuters) - AB SCIENCE SA:

* ANNOUNCED ON TUESDAY NEW PRECLINICAL DATA FOR MASITINIB IN ALS AT 2019 MUSCULAR DYSTROPHY ASSOCIATION CONFERENCE

* DATA PROVIDES FURTHER EVIDENCE ON MASITINIB’S MODE OF ACTION IN ALS VIA MODULATION OF NEUROGENIC INFLAMMATION

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below